期刊文献+
共找到249篇文章
< 1 2 13 >
每页显示 20 50 100
Serum cystatin C,monocyte/high-density lipoprotein-C ratio,and uric acid for the diagnosis of coronary heart disease and heart failure 被引量:1
1
作者 Ming Li Da-Hao Yuan +2 位作者 Zhi Yang Teng-Xiang Luw Xiao-Biao Zou 《World Journal of Clinical Cases》 SCIE 2024年第18期3461-3467,共7页
BACKGROUND Coronary heart disease(CHD)and heart failure(HF)are the major causes of morbidity and mortality worldwide.Early and accurate diagnoses of CHD and HF are essential for optimal management and prognosis.Howeve... BACKGROUND Coronary heart disease(CHD)and heart failure(HF)are the major causes of morbidity and mortality worldwide.Early and accurate diagnoses of CHD and HF are essential for optimal management and prognosis.However,conventional diagnostic methods such as electrocardiography,echocardiography,and cardiac biomarkers have certain limitations,such as low sensitivity,specificity,availability,and cost-effectiveness.Therefore,there is a need for simple,noninvasive,and reliable biomarkers to diagnose CHD and HF.AIM To investigate serum cystatin C(Cys-C),monocyte/high-density lipoprotein cholesterol ratio(MHR),and uric acid(UA)diagnostic values for CHD and HF.METHODS We enrolled 80 patients with suspected CHD or HF who were admitted to our hospital between July 2022 and July 2023.The patients were divided into CHD(n=20),HF(n=20),CHD+HF(n=20),and control groups(n=20).The serum levels of Cys-C,MHR,and UA were measured using immunonephelometry and an enzymatic method,respectively,and the diagnostic values for CHD and HF were evaluated using receiver operating characteristic(ROC)curve analysis.RESULTS Serum levels of Cys-C,MHR,and UA were significantly higher in the CHD,HF,and CHD+HF groups than those in the control group.The serum levels of Cys-C,MHR,and UA were significantly higher in the CHD+HF group than those in the CHD or HF group.The ROC curve analysis showed that serum Cys-C,MHR,and UA had good diagnostic performance for CHD and HF,with areas under the curve ranging from 0.78 to 0.93.The optimal cutoff values of serum Cys-C,MHR,and UA for diagnosing CHD,HF,and CHD+HF were 1.2 mg/L,0.9×10^(9),and 389μmol/L;1.4 mg/L,1.0×10^(9),and 449μmol/L;and 1.6 mg/L,1.1×10^(9),and 508μmol/L,respectively.CONCLUSION Serum Cys-C,MHR,and UA are useful biomarkers for diagnosing CHD and HF,and CHD+HF.These can provide information for decision-making and risk stratification in patients with CHD and HF. 展开更多
关键词 Serum cystatin C Monocyte/high-density lipoprotein-C ratio Uric acid Coronary heart disease Heart failure Risk stratification
下载PDF
Correlations between serum kidney injury molecule-1,cystatin C and immunosuppressants:A cross-sectional study of renal transplant patients in Bahrain
2
作者 Kannan Sridharan Shamik Shah +6 位作者 Mona Al Hammad Fatima Ali Mohammed Sindhan Veeramuthu Mona Abdulla Taher Mustafa Mohamed Hammad Lamees Jawad Eman Farid 《Journal of Biomedical Research》 CAS CSCD 2024年第3期269-277,共9页
Renal transplant patients receive several immunosuppressive drug regimens that are potentially nephrotoxic for treatment.Serum creatinine is the standard for monitoring kidney function;however,cystatin C(Cys C)and kid... Renal transplant patients receive several immunosuppressive drug regimens that are potentially nephrotoxic for treatment.Serum creatinine is the standard for monitoring kidney function;however,cystatin C(Cys C)and kidney injury molecule-1(KIM-1)have been found to indicate kidney injury earlier than serum creatinine and provide a better reflection of kidney function.Here,we assessed Cys C and KIM-1 serum levels in renal transplant patients receiving mycophenolate mofetil,tacrolimus,sirolimus,everolimus,or cyclosporine to evaluate kidney function.We used both the Chronic Kidney Disease Epidemiology Collaboration(CKD-EPI)2021 equation,which is based on creatinine and combined creatinine with Cys C,and the CKD-EPI 2012 equation,which is based on Cys C alone,to estimate glomerular filtration rate(GFR).Then,we assessed the association between serum KIM-1 and GFR<90 mL per minute per 1.73 m2.We observed significantly higher serum Cys C levels in patients with the elevated serum creatinine,compared with those with normal serum creatinine.The estimated GFRs based on creatinine were significantly higher than those based on the other equations,while a significant positive correlation was observed among all equations.Serum KIM-1 levels were negatively correlated with the estimated GFRs by the CKD-EPI Cys C and the combined creatinine with Cys C equations.A serum KIM-1 level above 0.71 ng/mL is likely to indicate GFR<90 mL per minute per 1.73 m2.We observed a significant correlation between serum creatinine and Cys C in our renal transplant patients.Therefore,serum KIM-1 may be used to monitor renal function when using potentially nephrotoxic drugs in renal transplants. 展开更多
关键词 KIM-1 cystatin C mycophenolate mofetil TACROLIMUS EVEROLIMUS SIROLIMUS CYCLOSPORINE
下载PDF
Evaluating new biomarkers for diabetic nephropathy:Role ofα2-macroglobulin,podocalyxin,α-L-fucosidase,retinol-binding protein-4,and cystatin C
3
作者 Jing-Jing Li Ru-La Sa +1 位作者 Yu Zhang Zhao-Li Yan 《World Journal of Diabetes》 SCIE 2024年第6期1212-1225,共14页
BACKGROUND The intricate relationship between type 2 diabetes mellitus(T2DM)and diabetic nephropathy(DN)presents a challenge in understanding the significance of various biomarkers in diagnosis.AIM To elucidate the ro... BACKGROUND The intricate relationship between type 2 diabetes mellitus(T2DM)and diabetic nephropathy(DN)presents a challenge in understanding the significance of various biomarkers in diagnosis.AIM To elucidate the roles and diagnostic values ofα2-macroglobulin(α2-MG),podocalyxin(PCX),α-L-fucosidase(AFU),retinol-binding protein-4(RBP-4),and cystatin C(CysC)in DN.METHODS From December 2018 to December 2020,203 T2DM patients were enrolled in the study.Of these,115 were diagnosed with DN(115 patients),while the remaining 88 patients were classified as non-DN.The urinary levels ofα2-MG,PCX,and AFU and the serum concentrations RBP-4 and CysC were measured in conjunction with other relevant clinical indicators to evaluate their potential correlations and diagnostic utility.RESULTS After adjustments for age and gender,significant positive correlations were observed between the biomarkers CysC,RBP-4,α2-MG/urinary creatinine(UCr),PCX/UCr,and AFU/UCr,and clinical indicators such as urinary albumin-to-creatinine ratio(UACR),serum creatinine,urea,24-h total urine protein,and neutrophil-to-lymphocyte ratio(NLR).Conversely,these biomarkers exhibited negative correlations with the estimated glomerular filtration rate(P<0.05).Receiver operating characteristic(ROC)curve analysis further demonstrated the diagnostic performance of these biomarkers,with UACR showcasing the highest area under the ROC curve(AUC^(ROC))at 0.97.CONCLUSION This study underscores the diagnostic significance ofα2-MG,PCX,and AFU in the development of DN.The biomarkers RBP-4,CysC,PCX,AFU,andα2-MG provide promising diagnostic insights,while UACR is the most potent diagnostic biomarker in assessing DN. 展开更多
关键词 Α2-MACROGLOBULIN Podocalysin Α-L-FUCOSIDASE Retinol binding protein-4 Cystatin C Diabetic nephropathy
下载PDF
Correlation between serum markers and transjugular intrahepatic portosystemic shunt prognosis in patients with cirrhotic ascites
4
作者 Xiao-Gang Hu Xiao-Xian Yang +5 位作者 Jun Lu Gang Li Jian-Ji Dai Jia-Min Wang Yi Deng Rui Feng 《World Journal of Gastrointestinal Surgery》 SCIE 2024年第2期481-490,共10页
BACKGROUND Individuals with refractory ascites in the context of liver cirrhosis typically face an adverse prognosis.The transjugular intrahepatic portosystemic shunt(TIPS)is an efficacious intervention,but there is a... BACKGROUND Individuals with refractory ascites in the context of liver cirrhosis typically face an adverse prognosis.The transjugular intrahepatic portosystemic shunt(TIPS)is an efficacious intervention,but there is a lack of reliable tools for postoperative pro-gnosis assessment.Previously utilized clinical biochemical markers,such as the serum albumin concentration(Alb),sodium(Na+)concentration,and serum creatinine(Scr),have limited predictive value.Therefore,the quest for novel,specific biomarkers to evaluate the post-TIPS prognosis in patients with liver cirrhosis and refractory ascites holds significant practical importance.A retrospective analysis was conducted on 75 patients with liver cirrhosis and refractory ascites who underwent TIPS at our institution from August 2019 to August 2021.These patients were followed up regularly for two years,and the death toll was meticulously documented.The patients were allocated into a survival group(n=45 patients)or a deceased group(n=30 patients)based on their prognosis status.The clinical data of the two groups were collected,and Child-Pugh scores and MELD scores were calculated for analysis.Spearman correlation analysis was carried out to evaluate the correlation of prognosis with Child-Pugh grade,MELD score,and Cys C level.Additionally,a multiple-factor analysis utilizing the Cox proportional hazard model was used to identify independent risk factors affecting the post-TIPS prognosis of patients with liver cirrhosis and refractory ascites.The receiver operating characteristic curve(ROC)ascertained the predictive value of the Cys C concen-tration,Child-Pugh grade,and MELD score for the prognosis of liver cirrhosis with refractory ascites in post-TIPS patients.RESULTS During a 2-year follow-up period,among 75 patients with liver cirrhosis and refractory ascites who underwent TIPS treatment,30 patients(40.00%)passed away.The deceased cohort exhibited heightened aspartate aminotrans-ferase,alanine aminotransferase,total bilirubin,Scr,prothrombin time,Cys C,international normalized ratio,Child-Pugh,and MELD scores compared to those of the survival cohort,while Alb and Na+levels were attenuated in the deceased group(P<0.05).Spearman analysis revealed moderate to high positive correlations between prognosis and Child-Pugh score,MELD score,and Cys C level(r=0.709,0.749,0.671,P<0.05).Multivariate analysis using the Cox proportional hazard model demonstrated that the independent risk factors for post-TIPS prognosis in patients with liver cirrhosis and refractory ascites were Cys C(HR=3.802;95%CI:1.313-11.015),Child-Pugh(HR=3.030;95%CI:1.858-4.943),and MELD(HR=1.222;95%CI:1.073-1.393)scores.ROC analysis confirmed that,compared to those of the classic prognostic models for Child-Pugh and MELD scores,the predictive accuracy of Cys C for post-TIPS prognosis in patients with liver cirrhosis and refractory ascites was slightly lower.This analysis yielded sensitivity and specificity values of 83.33%and 82.22%,respectively.The area under the curve value at this juncture was 0.883,with an optimal cutoff value set at 1.95 mg/L.CONCLUSION Monitoring the serum Cys C concentration is valuable for assessing the post-TIPS prognosis in patients with liver cirrhosis and refractory ascites.Predictive models based on serum Cys C levels,as opposed to Scr levels,are more beneficial for evaluating the condition and prognosis of patients with ascites due to cirrhosis. 展开更多
关键词 Liver cirrhosis Refractory ascites Transjugular intrahepatic portosystemic shunt Cystatin C
下载PDF
Exploring the Role of Serum Cystatin C in Early Detection of Acute Kidney Injury among On-Pump Cardiac Surgery Patients: A Single-Center Investigation in Bangladesh
5
作者 Md. Ahaduzzaman Md. Abir Tazim Chowdhury +8 位作者 Munama Magdum Md. Saiful Islam Khan Satyajit Sharma Monoj Tiwari Md. Abul Bashar Maruf Md. Alauddin Omar Sadeque Khan Md. Mostafizur Rahman Mirza Md. Nazmus Saquib 《World Journal of Cardiovascular Diseases》 CAS 2024年第6期363-373,共11页
Background: Acute Kidney Injury (AKI) stands as a prominent postoperative complication in on-pump cardiac surgery, with repercussions on morbidity, mortality, and hospitalization duration. Current diagnostic criteria ... Background: Acute Kidney Injury (AKI) stands as a prominent postoperative complication in on-pump cardiac surgery, with repercussions on morbidity, mortality, and hospitalization duration. Current diagnostic criteria relying on serum creatinine levels exhibit a delayed identification of AKI, prompting an exploration of alternative biomarkers. Aims and Objectives: This study is designed to overcome diagnostic constraints and explore the viability of serum Cystatin C as an early predictor of Acute Kidney Injury (AKI) in individuals undergoing on-pump cardiac surgery. The investigation aims to establish the relationship between serum Cystatin C levels and the onset of AKI in patients subjected to on-pump cardiac surgery. Primary objectives involve the assessment of the diagnostic effectiveness of serum Cystatin C, its comparison with serum creatinine, and the exploration of its potential for the early identification and treatment of AKI. Methodology: Conducted as a single-center study at the cardiac surgery department of BSMMU in Bangladesh from September 2020 to August 2022, a comparative cross-sectional analysis involved 31 participants categorized into No AKI and AKI groups based on Kidney Disease: Improving Global Outcomes (KDIGO) criteria. Data collection encompassed preoperative, post-CBP (cardiopulmonary bypass) conclusion at 2 hours, postoperative day 1, and postoperative day 2 intervals. Statistical analyses included Chi-squared tests, independent Student’s t-tests, and one-sample t-tests. Significance was set at P Results: The study revealed no significant differences in baseline characteristics between the No AKI and AKI groups, except for CPB time and cross-clamp time. Serum Cystatin C levels in the AKI group exhibited statistical significance at various time points, highlighting its potential as an early detector. Conversely, Serum Creatinine levels in the AKI group showed no statistical significance. The Receiver Operating Characteristic (ROC) curve analysis further supported the efficacy of serum Cystatin C, with an Area under the ROC Curve of 0.864 and a cut-off value of 0.55 (p Conclusion: This study supports the superior utility of serum Cystatin C as an early detector of AKI in on-pump cardiac surgery patients compared to serum creatinine. Its ability to identify AKI several hours earlier may contribute to reduced morbidity, mortality, and healthcare costs. The findings underscore the significance of exploring novel biomarkers for improved post-cardiac surgery renal function assessment. 展开更多
关键词 Acute Kidney Injury (AKI) On-Pump Cardiac Surgery Serum Cystatin C Serum Creatinine Diagnostic Biomarkers Early Detection Cardiopulmonary Bypass Single-Center Study BANGLADESH
下载PDF
Detection of decline in estimated glomerular filtration rate in patients with type 2 diabetes by cystatin C-based equations
6
作者 Tam Thai Thanh Tran Tien Kim Ha +2 位作者 Nhut Minh Phan Minh Van Le Tin Hoang Nguyen 《World Journal of Nephrology》 2024年第4期103-116,共14页
BACKGROUND Aging population is a significant issue in Viet Nam and across the globe.Elderly individuals are at higher risk of chronic kidney disease(CKD),especially those with diabetes.Several studies found that the e... BACKGROUND Aging population is a significant issue in Viet Nam and across the globe.Elderly individuals are at higher risk of chronic kidney disease(CKD),especially those with diabetes.Several studies found that the estimated glomerular filtration rate(eGFR)determined using creatinine-based equations was not as accurate as that determined using cystatin C-based equations.Cystatin C-based equations may be beneficial in elderly patients with an age-associated decline in kidney function.Early determination of eGFR decline and associated factors would aid in appropriate interventions to improve kidney function in elderly patients with diabetes.AIM To determine the utility of cystatin C-based equations in early detection of eGFR decline and to explore factors associated with eGFR decline in elderly patients with diabetes.METHODS This cross-sectional study included 93 participants aged≥60 years evaluated in Can Tho University of Medicine and Pharmacy Hospital between October 2022 and July 2023,including 47 and 46 participants with and without diabetes respectively,according to the American Diabetes Association criteria for diabetes.The kappa coefficient,Student’s t,Mann-Whitney,χ2,Pearson’s correlation,multivariate logistic regression,and multiple linear regression analyses were employed.RESULTS The eGFRs were lower with the cystatin C-based equations than with the creatinine-based equations.Good agreement was found between the Modification of Diet in Renal Disease(MDRD)and CKD Epidemiology Collaboration(CKD-EPI)2021 creatinine-cystatin C equations(kappa=0.66).In the diabetes group,30%of the participants had low eGFR.Both plasma glucose and glycated hemoglobin were associated with an increased risk of eGFR decline(P<0.05)and negatively correlated with eGFR(P=0.001).By multivariate logistic regression,total cholesterol,and exercise were independently associated with low eGFR.By multiple linear regression,higher plasma glucose levels were correlated with lower eGFR(P=0.026,r=-0.366).CONCLUSION Cystatin C-based equations were superior in the early detection of a decline in eGFR,and the MDRD equation may be considered as an alternative to the CKD-EPI 2021 creatinine-cystatin C equation.Exercise,plasma glucose,and total cholesterol were independently associated with eGFR in patients with diabetes. 展开更多
关键词 Cystatin C Estimated glomerular filtration rate ELDERLY DIABETES NEPHROLOGY Kidney function
下载PDF
血清NGAL和Cystatin C对糖尿病肾病早期诊断的意义研究 被引量:46
7
作者 童俊容 何凤 +5 位作者 罗正茂 张虹 王妍春 黄远航 王寅 张建林 《中国全科医学》 CAS CSCD 北大核心 2010年第8期810-812,共3页
目的探讨糖尿病肾病(DN)患者血清NGAL、CystatinC的改变及其对DN早期诊断的临床意义。方法选择2型糖尿病(T2DM)患者55例,根据尿清蛋白排泄率(UAER)分为3组,正常清蛋白尿(NA)组15例、微量清蛋白尿(MA)组17例、临床肾病(CN)组23例;同期选... 目的探讨糖尿病肾病(DN)患者血清NGAL、CystatinC的改变及其对DN早期诊断的临床意义。方法选择2型糖尿病(T2DM)患者55例,根据尿清蛋白排泄率(UAER)分为3组,正常清蛋白尿(NA)组15例、微量清蛋白尿(MA)组17例、临床肾病(CN)组23例;同期选取非肾病患者15例作为对照组。应用ELISA法检测患者血清NGAL(sNGAL)水平,应用免疫速率散射比浊法检测CystatinC水平,分析血清NGAL及Cystatin C水平与肾小球滤过率(GFR)之间的相关关系,应用受试者操作特征(ROC)曲线评价二者诊断DN的敏感度。结果(1)MA组、CN组患者血清NGAL和CystatinC水平均较对照组升高,差异有统计学意义(P<0.05),其中CN组患者血清NGAL和Cystatin C水平最高〔分别为(845.8±68.8)ng/ml和(3.58±1.21)mg/L〕。(2)Pearson相关分析:糖尿病患者血清NGAL和CystatinC水平与GFR均呈负相关(r值分别为-0.871和-0.792,P<0.01),且血清NGAL与GFR的相关性更密切。(3)两组患者血清NGAL和CystatinCROC曲线下的面积分别为0.839和0.720。结论糖尿病患者血清NGAL与GFR有较好的相关性,NGAL是诊断早期DN敏感而准确的指标,有望用于临床监测。 展开更多
关键词 NGAL CYSTATIN C 糖尿病肾病 早期诊断
下载PDF
检测肺癌患者血清Cathepsin X及Cystatin C的临床意义 被引量:9
8
作者 张学德 侯彦丽 +4 位作者 牛泽群 李维 孟夏 张娜 杨拴盈 《中国肺癌杂志》 CAS 北大核心 2013年第8期411-416,共6页
背景与目的组织蛋白酶X(Cathepsin X,Cat X)是最近发现的一种组织蛋白酶(Cathepsins,Cats)家族成员。近年来研究表明CatX与多种恶性肿瘤发生、发展有关。本研究旨在探讨肺癌患者血清CatX及cystatinC的表达与临床特征及预后的关系。方法... 背景与目的组织蛋白酶X(Cathepsin X,Cat X)是最近发现的一种组织蛋白酶(Cathepsins,Cats)家族成员。近年来研究表明CatX与多种恶性肿瘤发生、发展有关。本研究旨在探讨肺癌患者血清CatX及cystatinC的表达与临床特征及预后的关系。方法采用ELISA法定量检测84例肺癌患者及36例健康对照者血清CatX及cystatinC表达。结果肺癌患者血清Cat X和cystatin C水平明显高于健康人(P<0.01);CatX水平与肺癌病理类型之间有相关的趋势(P=0.076)。血清cystatin C水平与肺癌TNM分期正相关(P=0.01),cystatinC/CatX与淋巴结转移之间有相关趋势(P=0.058)。CatX表达水平与肺癌患者总生存期(overallsurvival,OS)相关,高水平CatX肺癌患者OS更短。Cox单因素回归示CatX高表达以及TNM分期是影响肺癌预后独立因素,Cox多因素回归显示,仅TNM分期是患者预后的独立危险因素。结论肺癌患者中血清CatX和cystatinC水平升高,检测肺癌患者Cat X和cystatin C血清水平对于指导临床肺癌诊断、评估预后有重要意义。 展开更多
关键词 CATHEPSIN X CYSTATIN C 肺肿瘤 血清
下载PDF
Cystatin家族的研究进展 被引量:13
9
作者 李国平 王秀琴 +2 位作者 刘芝华 王仑山 吴旻 《癌症》 SCIE CAS CSCD 北大核心 2001年第2期217-218,共2页
关键词 CYSTATIN 肿瘤浸润 细胞凋亡 肿瘤转移
下载PDF
测定血清Cystatin C浓度判断肾小球滤过率的临床意义 被引量:50
10
作者 罗长青 王玉梅 +2 位作者 邓安国 熊洁 付玲 《临床内科杂志》 CAS 北大核心 2003年第3期154-155,共2页
目的 验证测定血清CystatinC浓度作为判断肾小球滤过率 (GFR )指标的可行性。方法 对 40例不同肾功能状态的患者同时进行血清CystatinC浓度和99mTc DTPA清除率的测定 ,以99mTc DTPA清除率为标准方法 ,对两组结果进行相关分析。结果 ... 目的 验证测定血清CystatinC浓度作为判断肾小球滤过率 (GFR )指标的可行性。方法 对 40例不同肾功能状态的患者同时进行血清CystatinC浓度和99mTc DTPA清除率的测定 ,以99mTc DTPA清除率为标准方法 ,对两组结果进行相关分析。结果 血清CystatinC与99mTc DT PA清除率有高度相关性。结论 测定血清CystatinC浓度是一种敏感、准确、并可快速反映GFR的方法。 展开更多
关键词 CYSTATIN C 肾小球滤过率 清除率
下载PDF
猪Cystatin B基因cDNA克隆及遗传多态性分析 被引量:8
11
作者 陈磊 李学伟 +2 位作者 朱砺 李强 李明洲 《中国农业科学》 CAS CSCD 北大核心 2008年第7期2120-2127,共8页
【目的】研究猪肉嫩度性状候选基因-半胱氨酸蛋白酶抑制素B(Cystatin B,CSTB)基因对肌肉宰后嫩化的作用,为研究嫩度性状的遗传机理提供理论基础。【方法】采用RT-PCR结合克隆测序的方法,从猪肌肉组织总RNA中克隆到猪CSTB基因cDNA序列,... 【目的】研究猪肉嫩度性状候选基因-半胱氨酸蛋白酶抑制素B(Cystatin B,CSTB)基因对肌肉宰后嫩化的作用,为研究嫩度性状的遗传机理提供理论基础。【方法】采用RT-PCR结合克隆测序的方法,从猪肌肉组织总RNA中克隆到猪CSTB基因cDNA序列,并推导出其编码的氨基酸序列。采用PCR-RFLP方法,分析了84头猪CSTB基因多态性及其与嫩度性状的关联性。【结果】CSTB基因开放阅读框全长294bp,编码98个氨基酸。同源性分析结果表明,猪与人、鼠、牛的CSTB基因cDNA编码区(CDS)同源性分别为81%、85%和89%,推测氨基酸序列同源性为83%、76%和85%。蛋白质结构同源建模分析表明,该蛋白与人、鼠Cystatin B类似,具有stefin类蛋白酶抑制剂的典型空间结构,包括5条平行的β-sheet和负责与被抑制酶结合的楔形边缘。在CSTB基因第二内含子内PvuⅡ酶切位点检测到了AA、AB和BB这3种基因型,关联性分析表明AA基因型个体的各项嫩度指标均极显著低于另2种基因型的个体(P<0.01),最大剪切力为5.11kg,硬度值为19.31kg·s、平均剪切力为3.26kg。【结论】CSTB基因在不同物种间具有较高同源性,猪CSTB基因多态性与猪肉嫩度性状显著相关。 展开更多
关键词 CYSTATIN B基因 基因克隆 嫩度
下载PDF
胱抑素C在糖尿病肾病早期诊断中的应用 被引量:36
12
作者 王亚平 姜宇海 +1 位作者 余伟 张健峰 《临床检验杂志》 CAS CSCD 北大核心 2006年第3期240-240,共1页
临床上多用测定血清肌酐(SCr)和内生肌酐清除率(CCr)来分析肾小球滤过率(GFR),但影响它们的肾外因素很多。胱抑素C(Cystatin C)是一类小分子蛋白质,在体内由有核细胞产生,不受肾外因素的干扰,其产生速率恒定,且只通过肾小... 临床上多用测定血清肌酐(SCr)和内生肌酐清除率(CCr)来分析肾小球滤过率(GFR),但影响它们的肾外因素很多。胱抑素C(Cystatin C)是一类小分子蛋白质,在体内由有核细胞产生,不受肾外因素的干扰,其产生速率恒定,且只通过肾小球滤过排泄,具备作为GFR理想标志物的条件,实验研究SCr、CCr、Cystatin C之间的相关性,以阐明Cystatin C在糖尿病肾病早期诊断中的应用价值。 展开更多
关键词 血清胱抑素C(Cystatin C) 糖尿病肾病 肌酐清除率(CCr)
下载PDF
蛇毒cystatin基因转染抗人胃腺癌细胞体外侵袭作用的研究 被引量:9
13
作者 万榕 郑海音 +2 位作者 宋军 林旭 林建银 《中国肿瘤临床》 CAS CSCD 北大核心 2005年第17期961-965,共5页
目的:探讨蛇毒半胱氨酸蛋白酶抑制剂(sv-cystatin)对人胃腺癌细胞SGC7901侵袭转移的抑制作用。方法:采用人工拼接方法合成蛇毒cystatincDNA,构建pcDNA3.1/sv-cystatin真核表达质粒,经脂质体转染将pcDNA3.1/sv-cystatin质粒和pcDNA3.1质... 目的:探讨蛇毒半胱氨酸蛋白酶抑制剂(sv-cystatin)对人胃腺癌细胞SGC7901侵袭转移的抑制作用。方法:采用人工拼接方法合成蛇毒cystatincDNA,构建pcDNA3.1/sv-cystatin真核表达质粒,经脂质体转染将pcDNA3.1/sv-cystatin质粒和pcDNA3.1质粒分别导入胃腺癌细胞系SGC7901;利用RT-PCR和Westernblot检测SGC7901细胞中sv-cystatin基因的表达;应用细胞-基质粘附实验、细胞运动实验及重建基底膜侵袭实验分析sv-cystatin表达对SGC7901细胞粘附、运动和侵袭能力的影响。结果:转染sv-cystatin基因后,SGC/sv-cystatin细胞克隆中可检测到sv-cystatin的明显表达,SGC/sv-cystatin细胞的运动能力和体外穿越重建基底膜的能力明显低于转染空载体细胞和未转染的SGC7901细胞,但其体外粘附能力未见明显变化。结论:sv-cystatin基因的表达可使胃癌SGC7901细胞体外运动能力及侵袭能力明显减弱,提示sv-cystatin具有抑制胃癌细胞侵袭转移的作用。 展开更多
关键词 胃肿瘤 转染 蛇毒cystatin 表达
下载PDF
在肾脏疾病中检测血清Cystatin C的意义 被引量:19
14
作者 张雅君 王汉民 +1 位作者 陈威 宋朝君 《中国现代医学杂志》 CAS CSCD 2003年第10期47-49,共3页
目的 :探讨肾脏疾病中检测血清胱蛋白酶抑制剂以C(CystatinC)浓度评估肾小球滤过率 (GFR)的价值。方法 :应用酶联免疫吸附法 (ELISA) ,测定经临床及实验室检查证实有肾脏损害患者的血清CystatinC浓度 ,同时测定血肌酐 (Scr) ,尿素氮 (B... 目的 :探讨肾脏疾病中检测血清胱蛋白酶抑制剂以C(CystatinC)浓度评估肾小球滤过率 (GFR)的价值。方法 :应用酶联免疫吸附法 (ELISA) ,测定经临床及实验室检查证实有肾脏损害患者的血清CystatinC浓度 ,同时测定血肌酐 (Scr) ,尿素氮 (BUN)和血 β2 -微球蛋白 (β2 -GM) ,采用Cockcroft -Cault公式计算肌酐清除率 (Cockcroft) ,并用同位素99mTc -DTPA测定肾小球滤过率 ,血清CystatinC浓度分别与其它指标进行相关性分析。结果 :血清CystatinC浓度与β2 -GM (r=0 .69,P <0 .0 1) ;Scr(r=0 .63 5 ,P <0 .0 1) ;BUN(r=0 .5 49,P <0 .0 1呈正相关 ,与Cockcroft(r=- 0 .743 ,P <0 .0 1) ;99Tc -DTPA测定肾小球滤过率 (r =- 0 .791,P <0 .0 1呈负相关。结论 :临床上应用检测血清CystatinC浓度来评估肾功能是一种特异性高、准确性好、快速简单的方法。 展开更多
关键词 小球滤过率 CYSTATIN C 血肌酐
下载PDF
健康人群血清Cystatin C参考值调查及其对糖尿病肾损害诊断的作用 被引量:9
15
作者 邱谷 黄桥林 +2 位作者 陈红梅 戴世荣 张骆军 《现代检验医学杂志》 CAS 2007年第4期94-95,共2页
目的建立该地区健康成人血清Cystatin C的参考值范围,探讨其在糖尿病肾损害诊断中的作用。方法选择216名健康成人,按不同年龄段分组;根据尿中清蛋白(mAlb)的排出量将168例糖尿病患者分组,在HITACHI7060自动生化分析仪上,采用乳胶颗粒增... 目的建立该地区健康成人血清Cystatin C的参考值范围,探讨其在糖尿病肾损害诊断中的作用。方法选择216名健康成人,按不同年龄段分组;根据尿中清蛋白(mAlb)的排出量将168例糖尿病患者分组,在HITACHI7060自动生化分析仪上,采用乳胶颗粒增强免疫比浊法测定血清Cystatin C,免疫透射比浊法测定尿mAlb,酶法测定血清肌酐。结果健康成人血清Cystatin C呈正态分布,随着年龄增长Cystatin C水平呈上升趋势,以95%可信限作为健康成人血清Cystatin C的参考值,结果60y以下组为0.48~1.02mg/L,60y以上组为0.66~1.20mg/L;在糖尿病微量清蛋白尿期,Scr与对照组比较差异无统计学意义(P>0.05),而血清Cystatin C与对照组差异有统计学意义(P<0.05),提示血清Cys- tatin C对糖尿病肾损害诊断灵敏度明显高于Scr;经对部分糖尿病患者进行跟踪调查测定,证实单用尿mAlb诊断早期糖尿病肾病存在一定比例的假阳性,而Cystatin C的特异性较强。结论血清Cystatin C可作为一个良好的指标替代Scr用于临床评价GFR,血清Cystatin C联合尿mAlb测定可提高糖尿病早期肾损害诊断正确率。 展开更多
关键词 CYSTATIN C 参考值 糖尿病 肾损害
下载PDF
鼻咽癌患者血清MIP-3α与cystatin A表达及其临床意义 被引量:7
16
作者 李军 汤敏中 +7 位作者 陆爱英 钟伟铭 高健全 郑裕明 曾洪 陈万生 梁伟 蔡永林 《中国癌症杂志》 CAS CSCD 北大核心 2013年第10期845-851,共7页
背景与目的:目前,检测鼻咽癌的病灶残留、复发、远处转移,评价放化疗敏感性及判断预后主要依赖影像学的检查。寻找鼻咽癌早期诊断及预后相关的特异性分子标志物对鼻咽癌的早期诊断及个体化治疗具有重要意义。本研究通过检测血清巨噬细... 背景与目的:目前,检测鼻咽癌的病灶残留、复发、远处转移,评价放化疗敏感性及判断预后主要依赖影像学的检查。寻找鼻咽癌早期诊断及预后相关的特异性分子标志物对鼻咽癌的早期诊断及个体化治疗具有重要意义。本研究通过检测血清巨噬细胞炎性蛋白-3α(macrophage inflammatory protein-3α,MIP-3α)和cystatin A蛋白在鼻咽癌患者治疗前、后及健康人中的表达情况,探讨其在鼻咽癌诊断、与临床病理特征关系以及疗效评价中的作用。方法:应用定量酶联免疫吸附法检测140例初治无远处转移的鼻咽癌患者治疗前、治疗结束后血清中MIP-3α和cystatin A的表达情况,并以100名健康体检者为对照。结果:以血清MIP-3α水平为31 pg/mL及cystatin A水平为16 ng/mL诊断鼻咽癌的敏感度分别为92.1%及42.1%,特异度分别为86.0%及85.0%。140例鼻咽癌患者经过治疗后均达到完全缓解或者部分缓解。鼻咽癌患者治疗前血清MIP-3α和cystatin A水平显著高于治疗后和健康对照者。MIP-3α和cystatin A均与鼻咽癌临床分期相关,MIP-3α还与T分期有关。治疗后完全缓解患者的血清MIP-3α降至健康对照者水平。部分缓解患者仍高于健康对照者水平,而完全缓解与部分缓解患者的血清cystatin A均降至健康对照者水平。在1年内发生远处转移的患者治疗后血清MIP-3α和cystatin A水平均明显高于未发生远处转移患者和健康对照者。MIP-3α和cystatin A表达之间存在相关性。结论:血清MIP-3α水平作为辅助诊断鼻咽癌的指标有一定的临床意义。血清MIP-3α与cystatin A检测有助于判断鼻咽癌分期和治疗后的近期疗效。 展开更多
关键词 鼻咽癌 巨噬细胞炎性蛋白-3α CYSTATIN A 临床疗效
下载PDF
血清cystatin C,IgA/C3及IgA/C3检测在IgA肾病诊断及预后评估中的临床价值 被引量:6
17
作者 彭道荣 王菁 +5 位作者 邢瑞青 杨玉琪 张涛 吴永昌 程晓东 张小宁 《现代检验医学杂志》 CAS 2011年第6期52-54,57,共4页
目的 探讨IgA肾病患者血清cystatin C,IgA和IgA/C3比值在IgA肾病(IgAN)的诊断及预后中的临床价值.方法 应用乳胶增强散射比浊法测定62例IgAN患者和58例非IgAN患者血清cystatin C,IgA及C3含量,同时对检测结果进行分析.结果 ①IgAN患者... 目的 探讨IgA肾病患者血清cystatin C,IgA和IgA/C3比值在IgA肾病(IgAN)的诊断及预后中的临床价值.方法 应用乳胶增强散射比浊法测定62例IgAN患者和58例非IgAN患者血清cystatin C,IgA及C3含量,同时对检测结果进行分析.结果 ①IgAN患者血清cystatin C水平[(1.26±0.46)mg/L] 与非IgAN患者血清cystatin C[(1.66±1.17)mg/L] 水平比较,差异有统计学意义(t=-2.50,P〈0.05);IgAN患者血清IgA/C3比值(2.59±1.41)显著高于非IgAN患者(2.07±1.03),差异亦有统计学意义(t=2.33,P〈0.05);而血清IgA含量[(2.44±1.04)g/L]和C3 含量[(1.07±0.27)g/L] 与非IgAN患者比较差异均无统计学显著性意义;② Lee氏分级为Ⅲ,Ⅳ,V级的IgAN患者血清IgA水平及IgA/C3比值均显著高于Lee氏I和Ⅱ级,差异有统计学意义(t=-2.21,P〈0.05;t=-2.04,P〈0.05);③IgAN患者IgA水平〉3.0 g/L和IgA/C3比值≥2时诊断IgAN的敏感度、特异度、阳性预测值、阴性预测值及Youden指数YI分别为68.42%,51.48%,20.97%,89.66%,0.20和59.68%,56.90%,59.68%,56.90%,0.17.结论 血清IgA/C3比值联合IgA及cystatin C水平可作为IgAN鉴别诊断、病情判断、预后评估的参考指标;血清cystatin C可能是反映IgA肾病中肾小球滤过功能更为敏感的指标. 展开更多
关键词 IGA肾病 C3 IgA/C3比值 CYSTATIN C 检测
下载PDF
急性心肌梗塞病人血清巯基蛋白酶抑制肽C的变化 被引量:20
18
作者 冯建芳 汪淑荣 +4 位作者 李平 赵一鸣 孙诠 师树古 陈明哲 《基础医学与临床》 CSCD 1995年第4期45-47,共3页
采用兔抗人CystatinC抗体建立了酶联免疫吸附测定(ELISA)技术,对急性心肌梗塞病人急性发作期、恢复期及正常对照进行了测定。发现心梗急性发作期和恢复期血清cystatinC含量无明显变化,但均明显低于对照(P... 采用兔抗人CystatinC抗体建立了酶联免疫吸附测定(ELISA)技术,对急性心肌梗塞病人急性发作期、恢复期及正常对照进行了测定。发现心梗急性发作期和恢复期血清cystatinC含量无明显变化,但均明显低于对照(P<0.0l)。用Logistic回归模型校正年龄因素的影响后,上述差别仍然显著(P=0.041)。提示血清cystatinC浓度变化在一定程度上可作为急性心肌梗塞诊断的参考指标。此检测方法特异性强、灵敏度高、重复性好。 展开更多
关键词 心肌梗塞 巯基蛋白酶 CYSTATIN C 酶联免疫吸附
下载PDF
替米沙坦和苯磺酸氨氯地平联合降压对高血压合并冠心病心肾功能的影响 被引量:50
19
作者 林丹丹 路红 《中国老年学杂志》 CAS CSCD 北大核心 2013年第21期5291-5293,共3页
目的探讨替米沙坦联合氨氯地平治疗的降压效果及其心肾保护作用。方法选取2009年1月至2010年1月该科收治1 500例高血压合并冠心病患者作为研究对象,随机分为三组(替米沙坦组、氨氯地平组、替米沙坦联合氨氯地平治疗组),最终入选并随访成... 目的探讨替米沙坦联合氨氯地平治疗的降压效果及其心肾保护作用。方法选取2009年1月至2010年1月该科收治1 500例高血压合并冠心病患者作为研究对象,随机分为三组(替米沙坦组、氨氯地平组、替米沙坦联合氨氯地平治疗组),最终入选并随访成功90对(270例),收集患者的一般资料,对比观察药物治疗前、治疗1、3个月收缩压、舒张压、脉压、脑利钠肽前体(BNP)、血清Cystatin C和尿微量白蛋白的变化。结果用药治疗1个月,与替米沙坦组和氨氯地平组相比,联合治疗组收缩压、舒张压和脉压均显著降低〔(132.4±9.8)vs(139.5±10.8)vs(138.1±10.5)mmHg,P=0.018;(85.3±5.8)vs(89.2±5.9)vs(89.0±6.1)mmHg,P=0.012;(48.7±6.1)vs(51.6±5.8)vs(51.3±5.5)mmHg,P=0.034〕。用药治疗3个月,联合治疗组收缩压和脉压仍有显著降低的趋势〔(126.5±10.0)vs(134.2±9.8)vs(133.8±11.1)mmHg,P=0.022,(48.0±5.9)vs(50.7±6.0)vs(50.7±5.7)mmHg,P=0.038〕。与氨氯地平组相比,联合治疗组和替米沙坦组血清Cystatin C和尿微量白蛋白均显著降低〔(0.87±0.11)vs(0.84±0.13)vs(1.03±0.15),P=0.035,(68.0±15.9)vs(97.7±16.0)vs(100.7±17.7),P=0.028〕。结论替米沙坦组联合氨氯地平降压方案疗效明确,有效降低脉压可能减少心脑血管不良时间的发生,同时明显降低血清Cystatin C和尿微量白蛋白,可能有效延缓高血压导致的肾功能损害。 展开更多
关键词 高血压 冠心病 血清Cystatin C 尿微量白蛋白
下载PDF
检测血清胱抑素C诊断急性肾衰竭的研究 被引量:23
20
作者 彭炎强 史伟 +5 位作者 叶智明 梁馨苓 何朝生 章斌 王文健 梁永正 《新医学》 北大核心 2005年第10期570-572,共3页
目的:探讨血清胱抑素C(cystatin C)在诊断急性肾衰竭(acute renal failure,ARF)中的临床价值。方法:收集215例ICU病人的血标本,用酶法测定血清肌酐(serum creatinine,Scr),用颗粒增强透射免疫比浊法测定血清cystatinC,用Cockroft-Gault... 目的:探讨血清胱抑素C(cystatin C)在诊断急性肾衰竭(acute renal failure,ARF)中的临床价值。方法:收集215例ICU病人的血标本,用酶法测定血清肌酐(serum creatinine,Scr),用颗粒增强透射免疫比浊法测定血清cystatinC,用Cockroft-Gault公式计算肾小球滤过率(glomerular filtration rate,GFR),ARF诊断按ADQI标准。比较ARF病人与非ARF病人上述各指标。结果:41例ARF病人(观察组)血清cystatinC水平较174例非ARF病人(对照组)明显升高(P<0·01);ARF病人血清cys-tatinC与Scr呈正相关(r1=0·747,P<0·001)、与GFR呈负相关(r2=-0·808,P<0·001);以Scr升高达到或超过150%作为ARF的诊断标准时,ROC曲线分析显示血清cystatinC对ARF的诊断准确度高(曲线下面积为0·983)。结论:ARF时血清cystatinC明显升高,cystatinC可作为ICU危重病人并发ARF的诊断指标之一。 展开更多
关键词 急性肾衰竭 胱抑素C 肾小球滤过率 肌酐 血清胱抑素C 诊断标准 CYSTATIN ICU病人 failure 免疫比浊法测定
下载PDF
上一页 1 2 13 下一页 到第
使用帮助 返回顶部